If you’re looking to bolster your portfolio with some blue chip shares, you may want to look at the two listed below.
Here’s why these blue chip ASX 200 shares are highly rated right now:
CSL Limited (ASX: CSL)
The first blue chip ASX 200 share to look at is CSL. It is a leading biotechnology company behind the CSL Behring and Seqirus businesses.
These two businesses have a portfolio of life-saving and lucrative therapies and vaccines which save millions of lives and generate billions of dollars in sales each year.
But management isn’t resting on its laurels. It continues to invest in the region of 10% to 11% of its sales into research and development activities. This means it has a development pipeline filled to the brim with important and potentially lucrative therapies.
Furthermore, CSL is in the process of making a major acquisition. It is aiming to acquire Vifor Pharma later this year, which will add key renal therapies to its portfolio and development pipeline.
Citi is a fan and has a buy rating and $335.00 price target on CSL’s shares. Its analysts note that the “latest data points to continued improvement in plasma collection and strong underlying demand.”
Goodman Group (ASX: GMG)
Another blue chip ASX 200 share to look at is Goodman Group. It is a leading integrated commercial and industrial property company with a portfolio of in-demand properties with exposure to key growth markets such as ecommerce.
Goodman has continued to experience strong demand for its properties in FY 2022. This has led to strong rental growth and a sky high occupancy rate.
In light of this strong form, management has just upgraded its earnings guidance again. It is now expecting its earnings per share to grow 23% in FY 2022.
The team at Goldman Sachs expect this solid form to continue. The broker highlights that “GMG offers an estimated FY22-24e earnings CAGR of ~13%, screening more favourably on a growth adjusted basis relative to the coverage average of ~8%.”
As a result of this positive outlook, this week the broker has a reiterated its buy rating with an improved price target of $25.40.
The post 2 top blue chip ASX 200 shares to buy now according to experts appeared first on The Motley Fool Australia.
Wondering where you should invest $1,000 right now?
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.
*Returns as of January 12th 2022
More reading
- Top brokers name 3 ASX shares to buy today
- Why I would invest $10,000 into these ASX shares today
- Is the Telstra share price cheap compared to other ASX 200 shares?
- Why CSL shares are ‘going to deliver’ in 2022: fund manager
- ‘Future-proof your portfolio’: experts pick 3 quality growth ASX shares to buy
Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
from The Motley Fool Australia https://ift.tt/FV07DmM
Leave a Reply